Arexis AB
14Patents
7Active
14Granted
39Portfolio score
Filing activity: Nov 5, 1999 → Mar 3, 2020 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7872052B2 | Use of heterocyclic compounds as SCCE inhibitors | Human Necessities | 16 | Expired |
| US7208305B2 | Variants of the α1 subunit of human AMPK | Human Necessities | 3 | Expired |
| US7214850B2 | Transgenic mouse expressing Prkag3 | Chemistry; Metallurgy | 2 | Expired |
| US7148020B2 | Triple polypeptide complexes | Physics | 2 | Expired |
| US6465714B2 | Congenic animal models of non-insulin dependent diabetes mellitus | Human Necessities | 2 | Expired |
| US10625180B2 | Manufacturing method | Chemistry; Metallurgy | 0 | Active |
| US7943338B2 | Autoimmune conditions and NADPH oxidase defects | Physics | 0 | Active |
| US11180542B2 | Stabilized liquid anti-RSV antibody formulations | Chemistry; Metallurgy | 0 | Active |
| US7462693B2 | Variants of the Gamma Chain of AMPX, DNA sequences encoding the same, and uses thereof | Human Necessities | 0 | Active |
| US10604560B2 | Stabilized liquid anti-RSV antibody formulations | Chemistry; Metallurgy | 0 | Active |
| US7858369B2 | Expression constructs expressing Prkag3 | Chemistry; Metallurgy | 0 | Active |
| US7294652B2 | Autoimmune conditions and NADPH oxidase defects | Physics | 0 | Expired |
| US7476731B2 | Variants of the alpha 1 subunit of human AMPK | Human Necessities | 0 | Active |
| US7452982B2 | Immunogenic complex | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.